Evidence map›Paper›PMID 28130711›Full record

ArticleJournal of cancer survivorship : research and practice2017

The right to be forgotten: a change in access to insurance and loans after childhood cancer?

Agnès Dumas, Rodrigue Allodji, Brice Fresneau, Dominique Valteau-Couanet, Chiraz El-Fayech, Hélène Pacquement, Anne Laprie, Tan Dat Nguyen, Pierre-Yves Bondiau, Ibrahima Diallo and 6 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Journal of cancer survivorship : research and practice, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Models of Care for Survivors of Childhood Cancer From Across the Globe: Advancing Survivorship Care in the Next Decade.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2018
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 1 country.

Agnès DumasCentre for Research in Epidemiology and Population Health (CESP), Cancer and Radiation team, INSERM U1018, Université Paris-Sud, UVSQ, Université Paris-Saclay, 94807, Villejuif, France. agnes.dumas@gustaveroussy.fr.
Rodrigue AllodjiCentre for Research in Epidemiology and Population Health (CESP), Cancer and Radiation team, INSERM U1018, Université Paris-Sud, UVSQ, Université Paris-Saclay, 94807, Villejuif, France.
Brice FresneauCentre for Research in Epidemiology and Population Health (CESP), Cancer and Radiation team, INSERM U1018, Université Paris-Sud, UVSQ, Université Paris-Saclay, 94807, Villejuif, France.
Dominique Valteau-CouanetDepartment of Paediatric and Adolescent Oncology, Gustave Roussy, 94805, Villejuif, France.
Chiraz El-FayechDepartment of Paediatric and Adolescent Oncology, Gustave Roussy, 94805, Villejuif, France.
Hélène PacquementDepartment of Paediatric Oncology, Institut Curie, 75005, Paris, France.
Anne LaprieDepartment of Radiation Oncology, Centre Claudius Regaud, 31059, Toulouse, France.
Tan Dat NguyenRadiotherapy Department, Centre Jean Godinot, 51100, Reims, France.
Pierre-Yves BondiauDepartment of Radiation Oncology, Centre Antoine Lacassagne, 06100, Nice, France.
Ibrahima DialloCentre for Research in Epidemiology and Population Health (CESP), Cancer and Radiation team, INSERM U1018, Université Paris-Sud, UVSQ, Université Paris-Saclay, 94807, Villejuif, France.
Catherine GuiboutCentre for Research in Epidemiology and Population Health (CESP), Cancer and Radiation team, INSERM U1018, Université Paris-Sud, UVSQ, Université Paris-Saclay, 94807, Villejuif, France.
Carole RubinoCentre for Research in Epidemiology and Population Health (CESP), Cancer and Radiation team, INSERM U1018, Université Paris-Sud, UVSQ, Université Paris-Saclay, 94807, Villejuif, France.
Nadia HaddyCentre for Research in Epidemiology and Population Health (CESP), Cancer and Radiation team, INSERM U1018, Université Paris-Sud, UVSQ, Université Paris-Saclay, 94807, Villejuif, France.
Odile OberlinDepartment of Paediatric and Adolescent Oncology, Gustave Roussy, 94805, Villejuif, France.
Gilles VassalDepartment of Clinical Research, Gustave Roussy, 114 Rue Edouard Vaillant, 94805, Villejuif, France.
Florent de VathaireCentre for Research in Epidemiology and Population Health (CESP), Cancer and Radiation team, INSERM U1018, Université Paris-Sud, UVSQ, Université Paris-Saclay, 94807, Villejuif, France.
Institut Gustave Roussy · FRUniversité Paris-Saclay · FRUniversité Paris-Sud · FRCentre Antoine Lacassagne · FRCentre de recherche en Epidémiologie et Santé des Populations · FRInstitut Claudius Regaud · FRInstitut Curie · FRInstitut Jean Godinot · FRUniversité de Versailles Saint-Quentin-en-Yvelines · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAccess to insurance for a loan or a mortgage is an important issue for childhood cancer survivors. The aim of this study was to describe difficulties experienced by adult survivors.

methodsA total of 1920 survivors treated before the age of 18 in five French cancer centers responded to a questionnaire in 2010. Survivors who had tried to obtain a loan were asked if they had experienced difficulties, which were defined as experiencing rejection, higher premiums, or exclusions. The questionnaire investigated health problems related to the circulatory, respiratory, digestive, urinary, endocrine, hormonal, and nervous systems. Second tumors, diabetes mellitus, cardiac disease, and stroke were ascertained from a physician's report or medical records. Multivariable analyses were conducted to identify the characteristics of survivors reporting difficulties.

resultsDifficulties were experienced by 10.4% of those who had tried to obtain a small loan (n = 787) and by 30.1% of those who had tried to obtain a home loan (n = 909). Disclosure of childhood cancer to the insurer and amputation surgery were negatively associated with insurance accessibility, even when controlling for age, gender, education, health-related unemployment, familial situation, and severe or life-threatening conditions such as cardiovascular diseases, second cancers, or diabetes.

conclusionThis study showed that the financial burden of cancer can extend decades after diagnosis. IMPLICATIONS FOR CANCER SURVIVORS: Thanks to a 2016 law, French cancer survivors no longer have to disclose their cancer to insurers after a fixed number of years. This law will probably lessen the socioeconomic burden of cancer.

Indexed as

AdolescentAdultChildChild, PreschoolCohort StudiesFemaleFollow-Up StudiesHumansInsurance, HealthMaleNeoplasmsQuality of LifeSurvival RateCohort studiesDiscriminationEconomic burden of diseaseLong-term adverse effectsQuality of lifeSurvivorship

Identifiers

PMID28130711
OpenAlexW2582908432

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.